Related references
Note: Only part of the references are listed.N-Acylhydrazones as drugs
Sreekanth Thota et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Theoretical and experimental characterization of 1,4-N•••S σ-hole intramolecular interactions in bioactive N-acylhydrazone derivatives
Pedro de Sena Murteira Pinheiro et al.
NEW JOURNAL OF CHEMISTRY (2018)
Design, Synthesis, Experimental and Theoretical Characterization of a New Multitarget 2-Thienyl-N-Acylhydrazone Derivative
Isadora T. S. Bastos et al.
PHARMACEUTICALS (2018)
The Origin of Chalcogen-Bonding Interactions
Dominic J. Pascoe et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
A denosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction
Jaqueline S. da Silva et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Validation of a Na+-shift binding assay for estimation of the intrinsic efficacy of ligands at the A2A adenosine receptor
Francois Noel et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Modulation of GPCRs by monovalent cations and anions
Andrea Strasser et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2015)
N-acylhydrazone improves exercise intolerance in rats submitted to myocardial infarction by the recovery of calcium homeostasis in skeletal muscle
Jaqueline Soares da Silva et al.
LIFE SCIENCES (2014)
Functional binding assays for estimation of the intrinsic efficacy of ligands at the 5-HT1A receptor: Application for screening drug candidates
Francois Noel et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
Structure Re-determination of LASSBio-294-a cardioactive compound of the N-acylhydrazone class - using X-ray powder diffraction data
Fanny N. Costa et al.
POWDER DIFFRACTION (2013)
Design, Synthesis, and Pharmacological Evaluation of N-Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase-4 Inhibitors
Arthur E. Kuemmerle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The Methylation Effect in Medicinal Chemistry
Eliezer J. Barreiro et al.
CHEMICAL REVIEWS (2011)
LASSBio-294, A Compound With Inotropic and Lusitropic Activity, Decreases Cardiac Remodeling and Improves Ca2+ Influx Into Sarcoplasmic Reticulum After Myocardial Infarction
Daniele G. Costa et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294
Emmanuel O. Carneiro et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Characterization of the conformational ensemble from bioactive N-acylhydrazone derivatives
Laercio Pol-Fachin et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2010)
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives
Arthur E. Kummerle et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Expansion of the σ-hole concept
Jane S. Murray et al.
JOURNAL OF MOLECULAR MODELING (2009)
σ-hole bonding:: molecules containing group VI atoms
Jane S. Murray et al.
JOURNAL OF MOLECULAR MODELING (2007)
Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues
AG Silva et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Strategy of molecular simplification in rational drug design: The discovery of a new cardioactive agent
EJ Barreiro
QUIMICA NOVA (2002)
Cyclic GMP-dependent vasodilatory properties of LASSBio 294 in rat aorta
CLM Silva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The new compound, LASSBio 294, increases the contractility of intact and saponin-skinned cardiac muscle from Wistar rats
RT Sudo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole
PC Lima et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
